UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063651
Receipt number R000072848
Scientific Title Effects of vitamin D supplementation on the mental and physical health status of young women and their individual differences: a single-arm intervention study
Date of disclosure of the study information 2026/11/16
Last modified on 2026/11/16 17:31:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of vitamin D supplementation on mental and physical health and their individual differences in young women

Acronym

VD-MIND study

Scientific Title

Effects of vitamin D supplementation on the mental and physical health status of young women and their individual differences: a single-arm intervention study

Scientific Title:Acronym

Effects of vitamin D supplementation on the mental and physical health status of young women and their individual differences: a single-arm intervention study

Region

Japan


Condition

Condition

Healthy young women (mental and physical health status related to vitamin D deficiency/insufficiency)

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To examine (1) the association between mental and physical health status and vitamin D nutritional status, (2) the maintenance and improvement of mental and physical health status by vitamin D supplementation, and (3) whether single nucleotide polymorphisms (SNPs) in five genes involved in vitamin D metabolism influence the effect of vitamin D supplementation on mental and physical health status.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in mental and physical health scores (Beck Depression Inventory-II, trait anxiety of the State-Trait Anxiety Inventory-X, Perceived Stress Scale, and Cook-Medley Hostility Scale) from baseline to after 90 days of vitamin D supplementation

Key secondary outcomes

1) Change in serum 25-hydroxyvitamin D [25(OH)D] concentration before and after the intervention. 2) Association between baseline vitamin D nutritional status (serum 25(OH)D, vitamin D intake estimated by the food frequency questionnaire based on food groups [FFQg], and sun exposure assessed by a lifestyle questionnaire) and mental and physical health scores. 3) Association between changes in vitamin D nutritional status and changes in mental and physical health scores. 4) Association between SNP genotypes of GC (2 SNPs), VDR (5 SNPs), CYP2R1, CYP24A1, and CYP27B1 (1 SNP each) and changes in mental and physical health scores.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Participants take one tablet of a commercially available vitamin D3 supplement (Nature Made Super Vitamin D, Otsuka Pharmaceutical Co., Ltd,: 25 micro g vitamin D3 per tablet) once daily with water after lunch or dinner for 90 days. Intake is recorded by each participant in a personal planner or on a calendar sheet.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

30 years-old >

Gender

Female

Key inclusion criteria

Female undergraduate students in their first to third year at Wayo Women's University who provided written informed consent to participate in this study

Key exclusion criteria

1) Individuals with milk allergy (the test supplement contains milk components). 2) Individuals currently taking vitamin D supplements. 3) Individuals who are pregnant or breastfeeding.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Toshikazu
Middle name
Last name Suzuki

Organization

Wayo Women's University

Division name

Department of Health and Nutrition

Zip code

272-8533

Address

2-3-1 Konodai, Ichikawa, Chiba

TEL

047-371-1547

Email

t-suzuki@wayo.ac.jp


Public contact

Name of contact person

1st name Toshikazu
Middle name
Last name Suzuki

Organization

Wayo Women's University

Division name

Department of Health and Nutrition

Zip code

272-8533

Address

2-3-1 Konodai, Ichikawa, Chiba

TEL

047-371-1547

Homepage URL


Email

t-suzuki@wayo.ac.jp


Sponsor or person

Institute

Wayo Women's University

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science (JSPS)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee for Human Subjects, Wayo Women's University

Address

2-3-1 Konodai, Ichikawa, Chiba

Tel

047-371-1184

Email

k-rinri@wayo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 16 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/

Publication of results

Unpublished


Result

URL related to results and publications

https://center6.umin.ac.jp/

Number of participants that the trial has enrolled

124

Results

In a study involving 121 young women, supplementation with vitamin D3 (25 micro-g/day) for 90 days resulted in a decrease in the primary outcome measures: BDI-II (-4.8), STAI trait anxiety (-6.0), PSS (-4.3), and Ho (-1.8) scores. Although mean serum 25(OH)D levels increased from 33.6 nmol/L to 62.3 nmol/L, no clear association was found between this increase-or the participants' GC genotypes-and the changes in the mental health-related scores.

Results date posted

2026 Year 11 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The study population consisted of 121 women. The median age was 20 years (interquartile range: 19-20 years), and the median BMI was 20.4 kg/m2 (19.3-21.9 kg/m2). The mean serum 25(OH)D concentration was 33.6 nmol/L (standard deviation: 13.4), with 112 individuals (93%) exhibiting levels below 50 nmol/L (20 ng/mL).

Participant flow

124 participants were enrolled. Three withdrew before the intervention, and 121 completed the baseline assessment. Six did not attend the post-intervention assessment, and 115 completed the post-intervention blood sampling and questionnaires.

Adverse events

No serious adverse events related to the study were reported.

Outcome measures

In a study of 121 young women, supplementation with vitamin D3 (25 micro-g/day) for 90 days resulted in a decrease in scores for the primary outcome measures: BDI-II (-4.8), STAI trait anxiety (-6.0), PSS (-4.3), and Ho (-1.8). As there was no control group, it cannot be definitively concluded that these changes were caused by the vitamin D supplementation. Although mean serum 25(OH)D levels increased from 33.6 nmol/L to 62.3 nmol/L, neither this increase nor the participants' GC genotypes showed a clear association with the changes in mental health scores.

Plan to share IPD

No (consent for sharing individual participant data with third parties was not obtained)

IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 11 Month 07 Day

Date of IRB

2023 Year 11 Month 07 Day

Anticipated trial start date

2023 Year 11 Month 29 Day

Last follow-up date

2024 Year 04 Month 16 Day

Date of closure to data entry

2024 Year 06 Month 01 Day

Date trial data considered complete

2024 Year 06 Month 01 Day

Date analysis concluded

2027 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2026 Year 11 Month 16 Day

Last modified on

2026 Year 11 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072848